An Update On Retatrutide May 2025 .

The general pooled analysis showed a statistically significant percent reduction in body weight of the retatrutide group when contrasted to the placebo group after 36 weeks of therapy, with an overall MD of − 14.33 (95% CI: − 18.27 to − 10.39, P retatrutide side effects women</a> in overweight individuals with or without diabetic issues. Early trials of retatrutide disclosed that users can lose as much as a quarter of their body weight in under a year, making it virtually two times as effective as Ozempic.